Literature DB >> 2784742

The detection of anti-Sm-RNP activity in sera of patients with monoclonal gammopathies.

M Abu-Shakrah1, M Krupp, S Argov, D Buskila, H Slor, Y Shoenfeld.   

Abstract

The sera of 141 patients with monoclonal gammopathies were examined for the presence of anti-RNP and anti-Sm activities. An enzyme-linked immunosorbent assay (ELISA) was employed. Thirty-two sera were found to bind RNP while 16 bound to Sm. The anti-Sm and anti-RNP antibodies were found in sera of patients with IgG, IgM and IgA gammopathies. The activity against RNP and/or Sm was confirmed further by using purified immunoglobulins, employing competition assays and immunoblotting. Anti-Sm antibodies are regarded as being highly specific for SLE, yet none of the patients whose serum was found to contain high titres of anti-Sm/anti-RNP antibodies presented with symptoms related to SLE or other rheumatic diseases. Our results of a high incidence of anti-ribonucleoproteins activity in the serum of patients with monoclonal gammopathies support previous reports of autoantibody properties characteristic of these immunoglobulins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784742      PMCID: PMC1541950     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Profiles of antinuclear antibodies in systemic rheumatic diseases.

Authors:  D D Notman; N Kurata; E M Tan
Journal:  Ann Intern Med       Date:  1975-10       Impact factor: 25.391

2.  Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease.

Authors:  M D Parker
Journal:  J Lab Clin Med       Date:  1973-11

3.  Antibody activity of human myeloma globulins.

Authors:  M Seligmann; J C Brouet
Journal:  Semin Hematol       Date:  1973-04       Impact factor: 3.851

Review 4.  Myeloma proteins (M-components) with antibody-like activity.

Authors:  M Potter
Journal:  N Engl J Med       Date:  1971-04-15       Impact factor: 91.245

5.  IgG myeloma cryoglobulin with antistreptolysin activity.

Authors:  M Seligmann; F Danon; A Basch; J Bernard
Journal:  Nature       Date:  1968-11-16       Impact factor: 49.962

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.

Authors:  G C Sharp; W S Irvin; C M May; H R Holman; F C McDuffie; E V Hess; F R Schmid
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

8.  Characteristics of patients with serum antibodies to extractable nuclear antigens.

Authors:  J H Leibfarth; R H Persellin
Journal:  Arthritis Rheum       Date:  1976 Sep-Oct

9.  Human monoclonal macroglobulins with specificity for Klebsiella K polysaccharides that contain 3,4-pyruvylated-D-galactose and 4,6-pyruvylated-D-galactose.

Authors:  E A Kabat; J Liao; H Bretting; E C Franklin; D Geltner; B Frangione; M E Koshland; J Shyong; E F Osserman
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

10.  Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen.

Authors:  D M Winn; J F Wolfe; D A Lindberg; F H Fristoe; L Kingsland; G C Sharp
Journal:  Arthritis Rheum       Date:  1979-12
View more
  4 in total

1.  Antibodies to extractable nuclear antigens. Has technological drift affected clinical interpretation?

Authors:  R J Lock; D J Unsworth
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

Review 2.  Serologic laboratory findings in malignancy.

Authors:  Félix Fernández Madrid; Marie-Claire Maroun
Journal:  Rheum Dis Clin North Am       Date:  2011-11       Impact factor: 2.670

3.  The detection of antithyroglobulin activity in human serum monoclonal immunoglobulins (monoclonal gammopathies).

Authors:  N Yativ; D Buskila; M Blank; C L Burek; N R Rose; Y Shoenfeld
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

4.  Natural autoantibodies in sera of patients with Gaucher's disease.

Authors:  Y Shoenfeld; A Beresovski; D Zharhary; Y Tomer; M Swissa; E Sela; A Zimran; S Zevin; B Gilburd; M Blank
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.